An interventional study of Internet-based cognitive behavioral therapy and Non-directive support in Psychological Distress, Depression - Major Depressive Disorder and Insomnia, sponsored by Linkoeping University. Recruiting at 1 site in Sweden. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-24.
Sponsored by Linkoeping University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 58 studies in Sleep Initiation and Maintenance Disorders with a site in Sweden — 13 open to participants now, 15 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Sweden.
Among the 58 studies in Sleep Initiation and Maintenance Disorders with a site in Sweden, this one is the 20th largest by planned enrollment of the 54 interventional ones that give a count, is one of 5 that started in 2025, is one of 42 with no phase, reaches primary completion later than 6 of the 14 other live ones, and was the 55th registered.
2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.
Browse Sleep Initiation and Maintenance Disorders studies →13 of the 58 studies in Sleep Initiation and Maintenance Disorders with a site in Sweden are open now. Recruiting first, the newest first:
Malin Eleonora av Kák Gustafsson, MD, PhD · Sites in Sweden
Ages 18+
Uppsala University · Sites in Sweden
Ages 18–100
Lund University · Sites in Sweden
Ages 21+ · Healthy volunteers
Kristianstad University · Sites in Sweden
Ages 13–19 · Healthy volunteers
Karolinska Institutet · Sites in Sweden
Ages 18+ · Healthy volunteers
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.
This study: 18 Years and older · male · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
58 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 5 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 180 is above the median of 68 across 2,363 interventional studies indexed under Sleep Initiation and Maintenance Disorders.
Median enrollment 105 across the 54 interventional studies, 175 across the 4 observational. Of the 41 that completed or were terminated, 4 (10%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 58 have an industry lead sponsor. The 10 most frequent:
Linkoeping University is the lead sponsor of 193 studies on the registry; 40 are open to participants now.
Linkoeping University has 2 studies filed under Sleep Initiation and Maintenance Disorders — fewer than ten, so there is no comparison to draw.
3 of the studies in Sleep Initiation and Maintenance Disorders with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06145555Karolinska InstitutetAcute Psychological Sleep Stabilisation for Patients Hospitalised With Depression | 2026-12 |
| NCT06687304Lund UniversityLight in Healthcare Environment (Ljus i sjukhusmiljö) | 2027-03-31 |
| NCT04975776Region StockholmSleep Restriction Therapy for Insomnia in Primary Health Care | 2027-08-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 58 studies in Sleep Initiation and Maintenance Disorders with a site in Sweden, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study aims to study the efficacy of internet-based cognitive behavior therapy (ICBT) in reducing subjective distress and comorbid psychiatric symptoms in men diagnosed with prostate cancer. Participants who have been diagnosed with prostate cancer and are currently not undergoing or scheduled to undergo medical treatment will be recruited. Once recruited, they will be randomized to receive either a tailored, eight-week long ICBT intervention or an attention control group. Both group receive weekly support by a trained therapist.
Men diagnosed with prostate cancer frequently suffer from a wide range of psychological problems that can be traced to their disorder. Examples include depressed mood and worry regarding the prognosis and/or cancer recurrence. Psychological treatments can be used for helping cancer patients deal with this kind of distress, but frequently only targets one kind of symptoms.
This study investigates a tailored approach to providing help for men diagnosed with prostate cancer. Participants randomized to the treatment condition will receive an eight week ICBT intervention which is tailored to the problem profile of the participant in question. The treatment will last eight weeks and participants will receive weekly support and feedback from a therapist. Participants randomized to the control condition will receive weekly therapist support, but not access to the treatment modules. The primary outcome of interest is psychological distress, and other health-related outcomes will be measured as well. Participants will be recruited in Sweden with a nationwide recruitment.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
An eight week long ICBT treatment that is tailored to the problem profile of the participant. The treatment is modular, with one module being administered per week of the treatment.
Behavioral: Internet-based cognitive behavioral therapy
The control group will receive weekly support via contact with a therapist, without receiving access to the treatment modules.
Behavioral: Non-directive support
An eight week ICBT treatment. The treatment is modular and tailored to the problem profile of the participant. One module will be administered every week during the treatment phase.
Participants randomized to this condition will receive weekly support and contact with a therapist via the treatment platform. They will not have access to the treatment modules during the treatment phase.
Kessler-10 (K10)
Measure of psychological distress. Consists of 10 items. Higher scores indicate greater psychological distress. Scores can range between 10 and 50.
Time frame: At pretreatment, weekly during the treatment, after nine weeks, six months after completion of treatment, and twelve months after completion of treatment.
Fear of Cancer Recurrence Inventory, short form (FCRI)
Measure of fear of the cancer recurring and/or spreading. Consists of 9 items. Higher scores indicate greater fear/anxiety levels. Scores can range between 0 and 36.
Time frame: At pretreatment, after nine weeks, six months after completion of treatment, and twelve months after completion of treatment.
Generalized Anxiety Disorder-7 item scale (GAD-7)
Measure of symptoms of generalized anxiety disorder. Consists of seven items. Higher scores indicate greater anxiety. Scores can range between 0 and 21.
Time frame: At pretreatment, after nine weeks, six months after completion of treatment, and twelve months after completion of treatment.
Insomnia Severity Index (ISI)
Measure of insomnia and sleep related-difficulties. Consists of seven items. Higher scores indicate greater sleep related-difficulties. Scores can range from 0 to 28.
Time frame: At pretreatment, after nine weeks, six months after completion of treatment, and twelve months after completion of treatment.
Brunnsviken Brief Quality of Life Scale (BBQ)
Measure of quality of life. Consists of 12 items. Higher scores indicate a greater quality of life. Scores can range between 0 and 96.
Time frame: At pretreatment, after nine weeks, six months after completion of treatment, and twelve months after completion of treatment.
The EORTC Core Quality of Life questionnaire (EORTC QLQ-C30)
Measure of health-related quality of life. Consists of 30 items and three main subscales which each will serve as an outcome: Global health status, Functional status, and Symptom status. Higher scores indicate a greater health status within the domain. Scores can range between 0 and 100.
Time frame: At pretreatment, after nine weeks, six months after completion of treatment, and twelve months after completion of treatment.
The Illness Cognition Questionnaire (ICQ)
Measure of cognitions about the illness (in this case prostate cancer). Consists of 18 items. Analyzed separately as three subscales: Acceptance, Perceived benefits, and Helplessness. Greater scores indicate greater acceptance, more perceived benefits, and greater helplessness, respectively. Will also be used as mediators in a mediation analysis with the rate of change in subscale sum scores used as mediators. Sum scores for each subscale can range between 6 and 24.
Time frame: At pretreatment, weekly during the treatment, after nine weeks, six months after completion of treatment, and twelve months after completion of treatment.
Client Satisfaction Questionnaire-8 item version (CSQ-8)
Measure of treatment satisfaction. Consists of eight items. Higher scores indicate greater treatment satisfaction. Scores can range between 8 and 32.
Time frame: Measured after nine weeks of treatment.
Plan to share: Undecided
Started Jan 2025 (actual). Primary completion is estimated for Jun 2026, 17 months after the start.
Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 17 months is above that.
Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sleep Initiation and Maintenance Disorders →